In Alzheimer’s patients with depression, serum VEGF-A levels were found to be higher compared to those without depression, emphasizing the relationship between disease pathogenesis and elevated VEGF-A, an angiogenic cytokine [69]. This evidence concerns the gene VEGFA and depressive symptom measurement.